Trial Profile
A long term, non-interventional study investigating the effect of imatinib in gastrointestinal stroma tumours (GIST) after R0/R1 resection patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- Acronyms LOGIST
- 08 Dec 2015 New trial record